✦ LIBER ✦

Cost–Effectiveness of Clopidogrel Plus Aspirin for Stroke Prevention in Patients With Atrial Fibrillation in Whom Warfarin Is Unsuitable

✍ Scribed by Craig I. Coleman; Andrew D. Straznitskas; Diana M. Sobieraj; Jeffrey Kluger; Moise W. Anglade

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost–Effectiveness of Rivaroxaban Compar

✍ Soyon Lee; Moise W. Anglade; Dan Pham; Robyn Pisacane; Jeffrey Kluger; Craig I. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 786 KB

Cost-effectiveness of apixaban vs warfar

✍ Kamel, H.; Easton, J. D.; Johnston, S. C.; Kim, A. S. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 578 KB

PCV57 Cost-Effectiveness of Rivaroxaban

✍ A.K. Kapur; I. Chatzitheofilou; L.K. Schang 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

COST-EFFECTIVENESS OF APIXABAN COMPARED

✍ Soyon Lee; Moise Anglade; Kelly Hagstrom; Joy Meng; Jeffrey Kluger; Craig Colema 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Short-term prevention of thromboembolic

✍ Roberto Lorenzoni; Guido Lazzerini; Franca Cocci; Raffaele De Caterina 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Adjusted-dose warfarin versus low-intens

📂 Article 📅 1996 🏛 The Lancet 🌐 English ⚖ 53 KB